Company profile

Heuron Co., Ltd.

Heuron Co., Ltd. has 2 AI-enabled medical devices on the FDA list. The first decision was on October 13, 2023 and the most recent on May 15, 2024 (Heuron ICH). Its most common review panel is Radiology (2 devices).

2AI devices
2023First decision
2024Latest decision
1Specialties

Related guides

Timeline

  1. Heuron ICH · Radiology · QAS
  2. Veuron-Brain-pAb3 · Radiology · LLZ